logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

New coronoviral infection (COVID-19) in patients of the elderly and senile age

[Reviews]
Leonid Dvoretsky; Irina Sevastyanovna Komarova; Nadezhda Vladimirovna Mukhina; Natalia Alekseevna Cherkasova; Dyatlov Nikita V.;

The review is devoted to the peculiarities of the course of a new coronavirus infection (CОVID-19) in elderly and senile patients. Data on the epidemiology, pathogenetic mechanisms of development, clinical manifestations, course and prognosis of the disease among geriatric patients are presented. The role of comorbid pathology in the course and prognosis of a new coronavirus infection in the elderly is shown. Recommendations for the treatment of patients with an emphasis on the need to comply with strict indications for prescribing antibacterial drugs in this category of patients are discussed.

Download

References:
1. WHO Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2021/2/03. https://doi.org/covid19.who.int/
2. Zhang J., Litvinova M., Liang Y., Wang Y., Wang W. [et al.]. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 2020;368(6498):1481-1486. https://doi.org/10.1126/science.abb8001
3. Wang D., Hu B., Hu C., Zhu F., Liu X. [et al.]. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published correction appears in JAMA. 2021 16;325(11):1113]. JAMA. 2020;323(11):1061-1069. https://doi.org.10.1001/jama.2020
4. Yang X., Yu Y., Xu J., Shu H., Xia J. [et al.]. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020;8(4):e26]. Lancet Respir. Med. 2020;8(5):475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
5. Wu Z., McGoogan J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648
6. Central Bureau of Statistics. Sterfte in week 17 bij mensen met langdurige zorg 50 % hoger dan begin 2020. https://www.cbs.nl/nl-nl/nieuws/2020/19/sterfte-in-week-17-bijmensen-met-langdurige-zorg-50-hoger-dan-begin-2020.
Accessed June 27, 2020.
7. Gold J. A. W., Rossen L. M., Ahmad F. B., Sutton P., Li Z. [et al.]. Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 – United States, May-August 2020. Weekly. 2020;69(42):1517-1521.
8. Shahid Z., Kalayanamitra R., McClafferty B., Kepko D., Ramgobin D. [et al.]. COVID-19 and Older Adults: What We Know. J. Am. Geriatr. Soc. 2020;68(5):926-929. https://doi.org/10.1111/jgs.16472
9. Granados A., Peci A., McGeer A., Gubbay J. B. [et al.]. Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections. J. Clin. Virol. 2017;86:14-19. https://doi.org/10.1016/j.jcv.2016.11.008
10. To K. K., Tsang O. T., Leung W. S., Tam A. R., Wu T. C. [et al.]. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. 2020;20(5):565-574. https://doi.org/10.1016/S1473-3099(20)30196-1
11. Liu Y., Yan L. M., Wan L., Xiang T. X., Le A. [et al.]. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 2020;20(6):656-657. https://doi.org/10.1016/S1473-3099(20)30232-2
12. Moskalev A., Stambler I., Caruso C. Innate and Adaptive Immunity in Aging and Longevity: The Foundation of Resilience. Aging Dis. 2020;11(6):1363-1373. https://doi.org/10.14336/AD.2020.0603
13. Fulop T., Larbi A., Dupuis G., Le Page A., Frost E. H. [et al.]. Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? Front. Immunol. 2018;8:1960. https://doi.org/10.3389/fimmu.2017.01960
14. Pietrobon A. J., Teixeira F. M. E., Sato M. N. Immunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People. Front. Immunol. 2020;11:579220. https://doi.org/10.3389/fimmu.2020.579220
15. Meftahi G. H., Jangravi Z., Sahraei H., Bahari Z. [et al.]. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of «inflame-aging». Inflamm. Res. 2020;69(9):825-839. https://doi.org/10.1007/s00011-020-01372-8
16. Guaraldi G., Meschiari M., Cozzi-Lepri A., Milic J., Tonelli R. [et al.]. Tocilizumab in patients with severe COVID-19: a retrospective cohortstudy. Lancet Rheumatol. 2020;2(8):E474-484. https://doi.org/10.1016/S2665-9913(20)30173-9
17. Vaduganathan M., Vardeny O., Michel T., McMurray J. J. V., Pfeffer M. A. [et al.]. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N. Engl. J. Med. 2020;382(17):1653-1659. https://doi.org/10.1056/NEJMsr2005760
18. Al Ghatrif M., Cingolani O., Lakatta E. G. The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science. JAMA Cardiol. 2020;5(7):747-748. https://doi.org/10.1001/jamacardio.2020.1329
19. Mancia G., Rea F., Ludergnani M., Apolone G., Apolone G. [et al.]. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N. Engl. J. Med. 2020;382(25):2431-2440. https://doi.org/10.1056/NEJMoa2006923
20. Smorenberg A., Peters E. J., van Daele P., Nossent E. J., Muller M. [et al.]. How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur. J. Intern. Med. 2021;83: 1-5. https://doi.org/10.1016/j.ejim.2020.11.024
21. Jin Y., Yang H., Ji W., Wu W., Chen S. [et al.]. Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12(4):372. https://doi.org/10.3390/v12040372
22. Neumann-Podczaska A., Al-Saad S. R., Karbowski L. M. [et al.]. COVID 19 – Clinical Picture in the Elderly Population: A Qualitative Systematic Review. Aging Dis. 2020;11(4):988-1008. https://doi.org/10.14336/AD.2020.0620
23. Guo T., Shen Q., Guo W., He W., Li J. [et al.]. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study. Gerontology. 2020;66(5):467-475. https://doi.org/10.1159/000508734
24. Liu K., Chen Y., Lin R., Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J. Infect. 2020;80(6):e14-e18. https://doi.org/10.1016/j.jinf.2020.03.005
25. Olde Rikkert M. G. M., Vingerhoets R. W., van Geldorp N., de Jong N., Maas H. A. A. M. E. [et al.]. Atypisch beeld van COVID-19 bij oudere patiënten [Atypical clinical picture of COVID-19 in older patients]. Ned. Tijdschr. Geneeskd. 2020;164:D5004.
26. D’Adamo H., Yoshikawa T., Ouslander J. G. Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19. J. Am. Geriatr. Soc. 2020;68(5):912-917. https://doi.org/10.1111/jgs.16445
27. Wang W., Tang J., Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol. 2020;92(4):441-447. https://doi.org/10.1002/jmv.25689
28. Tian S., Hu N., Lou J., Chen K., Kang X. [et al.]. Characteristics of COVID-19 infection in Beijing. J. Infect. 2020;80(4):401-406. https://doi.org/10.1016/j.jinf.2020.02.018
29. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
30. Wang L., He W., Yu X., Hu D., Bao M. [et al.]. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J. Infect. 2020;80(6):639-645. https://doi.org/10.1016/j.jinf.2020.03.019
31. Guan W. J., Liang W. H., Zhao Y., Liang H. R., Chen Z. S. [et al.]. China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur. Respir. J. 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020
32. Chinnadurai R., Ogedengbe O., Agarwal P. [et al.]. Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study. BMC Geriatr. 2020;20(1):409. https://doi.org/10.1186/s12877-020-01803-5
33. Vanmassenhove J., Kielstein J., Jörres A. [et al.]. Management of patients at risk of acute kidney injury. Lancet. 2017;389(10084):2139-2151. https://doi.org/10.1016/S0140-6736(17)31329-6
34. Neto A. G., Lo K. B., Wattoo A., Salacup G., Pelayo J. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J. Med. Virol. 2020;93(3):1489-1495. https://doi.org/10.1002/jmv.26441
35. Gattinoni L., Coppola S., Cressoni M., Busana M., Rossi S., Chiumello D. COVID-19 Does Not Lead to a «Typical» Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 2020;15;201(10):1299-1300. https://doi.org/10.1164/rccm.202003-0817LE
36. Hwang J., Ryu H. S., Kim H. A., Hyun M., Lee J. Y. [et al.]. Prognostic Factors of COVID-19 Infection in Elderly Patients: A Multicenter Study. J. Clin. Med. 2020;9(12):3932. https://doi.org/10.3390/jcm9123932
37. Mostaza J. M., García-Iglesias F., González-Alegre T., Blanco F., Varas M, [et al.]. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population [published online ahead of print, 2020 Jul 27]. Arch. Gerontol. Geriatr. 2020;91:104204.
https://doi.org/10.1016/j.archger.2020.104204
38. Kuster G. M., Pfister O., Burkard T., Zhou Q., Twerenbold R. [et al.]. SARS-CoV2: should inhibitors of the renin– angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 2020;41(19):1801-1803. https://doi.org/10.1093/eurheartj/ehaa235
39. Zajcev A. A., Yakovlev S. V., Kozlov R. S. O primenenii antibakterialnoj terapii u pacientov s novoj koronavirusnoj infekciej COVID-19. Terapevticheskij arkhiv. – Therapeutic archive. 2020;92(11):4. (In Russ.).
40. Dieringer T. D., Furukawa D., Graber C. J., Stevens V. W., Jones M. M. [et al.]. Inpatient antibiotic utilization in the Veterans’ Health Administration during the coronavirus disease 2019 (COVID-19) pandemic. Infect. Control. Hosp. Epidemiol. 2020;20:1-3. https://doi.org/10.1017/ice.2020.1277
41. Karami Z., Knoop B. T., Dofferhoff A. S. M., Blaauw M. J. T., Janssen N. A. [et al.]. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicenter retrospective cohort study in The Netherlands. Infect. Dis. (Lond). 2020;53(2):102-110. https://doi.org/10.1080/23744235.2020.1839672
42. Rawson T. M., Moore L. S. P., Zhu N., Ranganathan N., Skolimowska K. [et al.]. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clin. Infect. Dis. 2020;71(9):2459-2468. https://doi.org/10.1093/cid/ciaa530
43. Odille G., Girard N., Sanchez S., Lelarge S., Mignot A. [et al.]. Should We Prescribe Antibiotics in Older Patients Presenting COVID-19 Pneumonia? J. Am. Med. Dir. Assoc. 2020;4:S1525-8610(20)31020-3. https://doi.org/10.1016/j.jamda.2020.11.034
44. Vremennye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19). Versiya 10. 08.02.21. MZ RF. (In Russ..
45. Tkacheva O. N., Kotovskaya Yu. V., Aleksanyan L. A., Milto A. S., Naumov A. V. [i dr.]. Soglasovannaya pozitsiya ekspertov Rossyskoy assotsiatsii gerontologov i geriatrov «Novaya koronovirusnaya infektsiya SARS-COV-2 u patsiyentov pozhilogo i starcheskogo vozrasta: osobennosti profilaktiki, diagnostiki i lecheniya» (Osnovnye polozheniya). Rossysky zhurnal geriatricheskoy meditsiny. – Russian journal of geriatric medicine. 2020;4:281-293. (In Russ.). https://doi.org/10.37586/2686-8636-4-2020-281-293

Keywords: new coronavirus infection, elderly patient, immunosuppression, comorbidity, antibacterial therapy


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy